{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:21:24Z","timestamp":1788009684594,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973878"],"award-info":[{"award-number":["No. 81973878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["Integration of Chinese and Western Medicine"],"award-info":[{"award-number":["Integration of Chinese and Western Medicine"]}]},{"name":"A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["(Nursing) with the No.2019YSHL154 and No.2019YSHL151"],"award-info":[{"award-number":["(Nursing) with the No.2019YSHL154 and No.2019YSHL151"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The prevalence of postmenopausal osteoporosis is rapidly rising, with a high proportion of patients who are vulnerable to fractures and other chronic symptoms. The commonly applied Western medicine lacks cost-efficiency and tends to have various potential side effects. Guilu Erxian Glue (GEG), an orally taken traditional Chinese medicinal product, has been advocated to manage osteoporosis for a long period. However, the evidence of the efficacy of GEG on osteoporosis seems to be less convincing and conclusive. Therefore, the purpose of this study is to assess the effectiveness and safety of GEG on postmenopausal osteoporosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will implement a systematic review and meta-analysis following the requests of the preferred reporting items for systematic reviews and meta-analyses protocols (PRISMA-P). The PubMed database, Scopus, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, VIP database, Sinomed, and grey literature sources will be retrieved for eligible studies. Randomized controlled trials investigating GEG in women with postmenopausal osteoporosis employing osteoporosis-associated outcomes measures will be eligible for inclusion. Two reviewers will independently complete the study selection procedure, data extraction, and risk of bias assessment. A third reviewer will mediate when irreconcilable discrepancies occur. Should sufficient clinical homogeneity exist, a meta-analysis will be conducted. Additionally, we will utilize the Grading of Recommendations Assessment, Development and Evaluation to assess the strength of quantitative outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The current systematic review and meta-analysis will provide the effectiveness and safety of GEG on postmenopausal osteoporosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The study will offer high-quality and explicit evidence for applying GEG on the treatment of postmenopausal osteoporosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OSF Registration:<\/jats:title>\n            <jats:p>DOI 10.17605\/OSF.IO\/JCVBH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020773","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T18:00:52Z","timestamp":1595008852000},"page":"e20773","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness and safety of Guilu Erxian Glue (a traditional Chinese medicinal product) for the treatment of postmenopausal osteoporosis"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-2883","authenticated-orcid":false,"given":"Yuhao","family":"Si","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[{"name":"School of Nursing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Nanjing University of Chinese Medicine, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-4395","authenticated-orcid":false,"given":"Heng","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Traumatology & Orthopedics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2017.21640","article-title":"Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US Preventive Services Task Force","volume":"319","author":"Kahwati","year":"2018","journal-title":"JAMA"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13697137.2018.1433655","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials","volume":"21","author":"Liu","year":"2018","journal-title":"Climacteric"},{"key":"R3-20230915","first-page":"1203","article-title":"Prevalence of osteoporosis in patients with Type 2 diabetes mellitus in the Chinese Mainland: a systematic review and meta-analysis","volume":"48","author":"Si","year":"2019","journal-title":"Iran J Public Health"},{"key":"R4-20230915","first-page":"9","article-title":"Primary osteoporosis in postmenopausal women","volume":"1","author":"Ji","year":"2015","journal-title":"Chronic Dis Transl Med"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"R7-20230915","first-page":"OC04","article-title":"Study of adverse effect profile of parenteral zoledronic acid in female patients with osteoporosis","volume":"10","author":"Kotian","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20780","article-title":"A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures","volume":"20","author":"Davis","year":"2016","journal-title":"Health Technol Assess"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40266-018-0525-7","article-title":"Denosumab: a review in postmenopausal osteoporosis","volume":"35","author":"Deeks","year":"2018","journal-title":"Drugs Aging"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archinte.166.11.1209","article-title":"The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis","volume":"166","author":"Liu","year":"2006","journal-title":"Arch Intern Med"},{"key":"R11-20230915","first-page":"947","article-title":"Adjuvant function of guilu erxian glue cataplasm in treating carcinoma of the large intestine patients with myelosuppression after chemotherapy: a clinical observation","volume":"34","author":"Wang","year":"2014","journal-title":"Chin J Integr Med"},{"key":"R12-20230915","first-page":"65","article-title":"Adverse events assessment of traditional Chinese herbal product, Guilu Erxian Jiao, in healthy volunteers","volume":"22","author":"Lin","year":"2011","journal-title":"J Chin Med"},{"key":"R13-20230915","first-page":"29","article-title":"Clinical observation of Guilu Erxian Glue for primary osteoporosis with Yin and Yang deficiency of kidney syndrome","volume":"5","author":"Wang","year":"2018","journal-title":"J New Chin Med"},{"key":"R14-20230915","first-page":"165","article-title":"Clinical evaluation of Guilu Erxian Jiao in treating perimenopausal syndrome","volume":"23","author":"Wang","year":"2012","journal-title":"J Chin Med"},{"key":"R15-20230915","first-page":"5","article-title":"Clinical observation on influence of Erxian Yanggu Tang and fosamax on bone density and cytokine of postmenopausal osteoporosis","author":"Jianwu","year":"2008","journal-title":"J Trad Chin Orthop Traumatol"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:27:20Z","timestamp":1694827640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020773"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":17,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020773","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}